IRF4 – a factor for class switching and antibody secretion

被引：0

作者：

Simon Fillatreau

Andreas Radbruch

机构：

[1] Deutsches Rheuma-Forschungszentrum,

来源：

Nature Immunology | 2006年 / 7卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Cognate antigen triggers B cells to undergo antibody maturation and terminal differentiation into antibody-secreting plasma cells. The transcription factor IRF4, which is essential for early B cell development, is also influential at these later stages of B cell development and function.

引用

页码：704 / 706

页数：2

共 50 条

[41] IRF4 Shapes the Tumor Microenvironment of Follicular Lymphoma
Mondello, Patrizia
Wenzl, Kerstin
Yang, Zhi-Zhang
Hong, Changjin
Krull, Jordan E.
Tang, Xinyi
Bhardwaj, Vaishali
Novak, Joseph P.
Kim, Hyojin
Mukherjee, Prithviraj
King, Rebecca L.
Hwang, Tae Hyun
Shlomchik, Mark J.
Novak, Anne J.
Ansell, Stephen M.
BLOOD, 2022, 140
[42] The dynamic functions of IRF4 in B cell malignancies
Maffei, Rossana
Fiorcari, Stefania
Atene, Claudio Giacinto
Martinelli, Silvia
Mesini, Nicolo
Pilato, Flora
Lagreca, Ivana
Barozzi, Patrizia
Riva, Giovanni
Nasillo, Vincenzo
Paolini, Ambra
Forghieri, Fabio
Potenza, Leonardo
Trenti, Tommaso
Tagliafico, Enrico
Luppi, Mario
Marasca, Roberto
CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (04) : 1171 - 1180
[43] Human inborn errors of immunity associated with IRF4
Thouenon, Romane
Kracker, Sven
FRONTIERS IN IMMUNOLOGY, 2023, 14
[44] IRF4: COMMON REGULATORY ROLE IN CHILDHOOD LEUKEMIA?
Adamaki, M.
Lambrou, G.
Athanasiadou, A.
Divane, A.
Tzanoudaki, M.
Vlahopoulos, S.
Moschovi, M.
PEDIATRIC BLOOD & CANCER, 2013, 60 : 221 - 221
[45] A decisive role of IRF4 for Tfh cell development
Bollig, N.
Bruestle, A.
Kellner, K.
Brendel, C.
Huber, M.
Kroczek, R. A.
Dong, C.
Jacob, R.
Mak, T. W.
Lohoff, M.
IMMUNOLOGY, 2012, 137 : 7 - 7
[46] Critical Functions of IRF4 in B and T Lymphocytes
Hagman, James
JOURNAL OF IMMUNOLOGY, 2017, 199 (11): : 3715 - 3716
[47] Super-enhancer analysis defines IRF4 as a target in anaplastic large cell lymphoma and rational design of IRF4 degrader molecules
Giordano, C.
Prutsch, N.
Gurnhofer, E.
Aplenc, A.
Kenner, L.
Look, A. T.
Touaibia, M.
Merkel, O.
ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 264 - 264
[48] IRF4 haploinsufficiency in a family with Whipple's disease
Guerin, Antoine
Kerner, Gaspard
Marr, Nico
Markle, Janet G.
Fenollar, Florence
Wong, Natalie
Boughorbel, Sabri
Avery, Danielle T.
Ma, Cindy S.
Bougarn, Salim
Bouaziz, Matthieu
Beziat, Vivien
Della Mina, Erika
Oleaga-Quintas, Carmen
Lazarov, Tomi
Worley, Lisa
Tina Nguyen
Patin, Etienne
Deswarte, Caroline
Martinez-Barricarte, Ruben
Boucherit, Soraya
Ayral, Xavier
Edouard, Sophie
Boisson-Dupuis, Stephanie
Rattina, Vimel
Bigio, Benedetta
Vogt, Guillaume
Geissmann, Frederic
Quintana-Murci, Lluis
Chaussabel, Damien
Tangye, Stuart G.
Raoult, Didier
Abel, Laurent
Bustamante, Jacinta
Casanova, Jean-Laurent
ELIFE, 2018, 7
[49] The dynamic functions of IRF4 in B cell malignancies
Rossana Maffei
Stefania Fiorcari
Claudio Giacinto Atene
Silvia Martinelli
Nicolò Mesini
Flora Pilato
Ivana Lagreca
Patrizia Barozzi
Giovanni Riva
Vincenzo Nasillo
Ambra Paolini
Fabio Forghieri
Leonardo Potenza
Tommaso Trenti
Enrico Tagliafico
Mario Luppi
Roberto Marasca
Clinical and Experimental Medicine, 2023, 23 : 1171 - 1180
[50] The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival
Fedele, Pasquale L.
Liao, Yang
Gong, Jia-nan
Yao, Yuan
van Delft, Mark F.
Low, Michael S. Y.
Tai, Lin
Herold, Marco J.
Jackson, Jacob T.
Teh, Charis E.
Tan, Tania
O'Reilly, Lorraine A.
Tellier, Julie
Grigoriadis, George
Huang, David C. S.
Shi, Wei
Nutt, Stephen L.
Willis, Simon N.
LEUKEMIA, 2021, 35 (07) : 2114 - 2118

← 1 2 3 4 5 →